GlaxoSmithKline S.A.E (EGX:BIOC)

Egypt flag Egypt · Delayed Price · Currency is EGP
67.17
-0.81 (-1.19%)
At close: Apr 28, 2026
76.21%
Market Cap 5.61B
Revenue (ttm) 3.73B
Net Income (ttm) 213.23M
Shares Out 83.51M
EPS (ttm) 2.55
PE Ratio 26.31
Forward PE n/a
Dividend 1.00 (1.47%)
Ex-Dividend Date Jan 12, 2026
Volume 37,868
Average Volume 104,778
Open 67.98
Previous Close 67.98
Day's Range 66.70 - 68.42
52-Week Range 34.34 - 81.50
Beta 0.76
RSI 61.90
Earnings Date May 18, 2026

About GlaxoSmithKline S.A.E

GlaxoSmithKline S.A.E engages in production of pharmaceutical chemicals. The company is involved in manufacture of general and specialty medicines, and vaccines. GlaxoSmithKline S.A.E was founded in 1981 and is based in New Cairo, Egypt. GlaxoSmithKline S.A.E operates as a subsidiary of Glaxo Group Limited. [Read more]

Industry Pharmaceutical Preparations
Founded 1981
Employees 800
Stock Exchange Egyptian Stock Exchange
Ticker Symbol BIOC
Full Company Profile

Financial Performance

In 2025, GlaxoSmithKline S.A.E's revenue was 3.73 billion, an increase of 24.73% compared to the previous year's 2.99 billion. Earnings were 213.23 million, an increase of 22.56%.

Financial Statements

News

There is no news available yet.